MA on gene patents
November 28, 2011
MEDICINES Australia has thrown
its weight behind the Government’s
Raising the Bar Bill, which supports
gene patents for genetic materials.
Currently before Parliament, the
Bill, according to Medicines
Australia, will bring Australia’s
intellectual property system into
line with intellectual property
systems in other OECD countries.
“Patents on biological materials
are important because they
guarantee ongoing investment in
developing cutting-edge medicines
and therapies,” said the Chief
Executive of Medicines Australia, Dr
Brendan Shaw.
“There is no doubt that Australia’s
patent system needs to be
reformed.
“The Raising the Bar Bill, is more
balanced and constructive than the
proposed ban on gene patents,” he
added.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Nov 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Nov 11
